| Dr Marisol Rodriguez-hernandez, MD | |
|
1785 Carr 21, Suite 95, San Juan, PR 00921-3399 | |
| (787) 774-5555 | |
| (787) 774-5767 |
| Full Name | Dr Marisol Rodriguez-hernandez |
|---|---|
| Gender | Female |
| Speciality | Radiation Oncology |
| Experience | 45 Years |
| Location | 1785 Carr 21, San Juan, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639153679 | NPI | - | NPPES |
| 85063 | Other | PR | PROVIDER NUMBER, OFFICE AT AGUADILLA, PR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 7411 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metrohealth Radiation Oncology Group, Inc. | 6507854254 | 5 |
News Archive
Carter and Conner, conjoined twin boys born Dec. 12, 2014, in Jacksonville, Fla., underwent a successful separation surgery on May 7, 2015. The 12-hour surgery was led by a team of highly skilled pediatric specialists that included Daniel Robie, MD, chief of pediatric general surgery, and Nicholas Poulos, MD, pediatric general surgeon, for Nemours Children's Specialty Care and Wolfson Children's Hospital.
Drinking Montmorency concentrate significantly helps to reduce the effects of the painful condition gout, according to new research.
Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.
Boehringer Ingelheim will announce positive results from the landmark RE-COVER™ study at the 51st Annual Meeting of the American Society of Hematology on 6 December 2009. The RE-COVER™ study assessed dabigatran etexilate in a head-to-head comparison with the current standard in care, warfarin, for the treatment of acute venous thromboembolism (VTE), enabling healthcare professionals to make direct comparisons and care based value judgements.
Exposure to radiation from imaging equipment is constantly subjected to scrutiny from regulatory authorities. Ultrasound poses no radiation threat and is constantly further developed to accentuate primary and secondary diagnosis. The next wave in ultrasound technology will witness advancements in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis.
› Verified 7 days ago
| Entity Name | Metrohealth Radiation Oncology Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952388258 PECOS PAC ID: 6507854254 Enrollment ID: O20050601000892 |
News Archive
Carter and Conner, conjoined twin boys born Dec. 12, 2014, in Jacksonville, Fla., underwent a successful separation surgery on May 7, 2015. The 12-hour surgery was led by a team of highly skilled pediatric specialists that included Daniel Robie, MD, chief of pediatric general surgery, and Nicholas Poulos, MD, pediatric general surgeon, for Nemours Children's Specialty Care and Wolfson Children's Hospital.
Drinking Montmorency concentrate significantly helps to reduce the effects of the painful condition gout, according to new research.
Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.
Boehringer Ingelheim will announce positive results from the landmark RE-COVER™ study at the 51st Annual Meeting of the American Society of Hematology on 6 December 2009. The RE-COVER™ study assessed dabigatran etexilate in a head-to-head comparison with the current standard in care, warfarin, for the treatment of acute venous thromboembolism (VTE), enabling healthcare professionals to make direct comparisons and care based value judgements.
Exposure to radiation from imaging equipment is constantly subjected to scrutiny from regulatory authorities. Ultrasound poses no radiation threat and is constantly further developed to accentuate primary and secondary diagnosis. The next wave in ultrasound technology will witness advancements in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marisol Rodriguez-hernandez, MD Po Box 191625, San Juan, PR 00919-1625 Ph: (787) 774-5555 | Dr Marisol Rodriguez-hernandez, MD 1785 Carr 21, Suite 95, San Juan, PR 00921-3399 Ph: (787) 774-5555 |
News Archive
Carter and Conner, conjoined twin boys born Dec. 12, 2014, in Jacksonville, Fla., underwent a successful separation surgery on May 7, 2015. The 12-hour surgery was led by a team of highly skilled pediatric specialists that included Daniel Robie, MD, chief of pediatric general surgery, and Nicholas Poulos, MD, pediatric general surgeon, for Nemours Children's Specialty Care and Wolfson Children's Hospital.
Drinking Montmorency concentrate significantly helps to reduce the effects of the painful condition gout, according to new research.
Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.
Boehringer Ingelheim will announce positive results from the landmark RE-COVER™ study at the 51st Annual Meeting of the American Society of Hematology on 6 December 2009. The RE-COVER™ study assessed dabigatran etexilate in a head-to-head comparison with the current standard in care, warfarin, for the treatment of acute venous thromboembolism (VTE), enabling healthcare professionals to make direct comparisons and care based value judgements.
Exposure to radiation from imaging equipment is constantly subjected to scrutiny from regulatory authorities. Ultrasound poses no radiation threat and is constantly further developed to accentuate primary and secondary diagnosis. The next wave in ultrasound technology will witness advancements in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis.
› Verified 7 days ago
Bernardo Jose Marques Diaz, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 310 Lomas Verdes Ave. Suite 208, San Juan, PR 00927 Phone: 787-751-3150 Fax: 787-767-0338 | |
Dr. Roberto F Marchan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 271 Ave J T Pinero, San Juan, PR 00927 Phone: 787-759-9660 Fax: 787-759-9660 | |
Wilmarie Rivera Hernandez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 617 Calle Manuel Pavia, San Juan, PR 00909 Phone: 787-625-1446 | |
Dr. Wilma Rodriguez Mojica, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Fernandez Street No. 6 , Third Floor, San Juan, PR 00918 Phone: 787-763-6336 Fax: 787-763-6207 | |
Luis Garcia Paredes, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1462 Calle Prof Augusto Rodriguez, San Juan, PR 00909 Phone: 787-641-1616 | |
Mr. Roberto J Sein, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Ave De Diego 201, Plaza San Fco Ofic #30, San Juan, PR 00927 Phone: 787-751-5587 Fax: 787-753-4631 | |
Dr. Ivonne Marquez Valencia, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 258 Calle San Jorge, San Juan, PR 00912 Phone: 787-727-1000 |